GSDMD and Stroke: Two days post-stroke with no treatment (Group B), GSDMD-positive cells were prominently present in penumbra region near the hypoxic core, with a majority co-expressing IBA1 or GFAP, indicating expression in both microglia and astrocytes (Figures 2DA–DE).